Lobesug Tablets contain Lobeglitazone 0.5 mg, a prescription oral antidiabetic medication used for the management of Type 2 Diabetes Mellitus. Lobeglitazone belongs to the thiazolidinedione (TZD) class and works by improving insulin sensitivity, thereby helping maintain optimal blood glucose levels.
This medication is particularly beneficial for patients with insulin resistance, a core factor in the progression of type 2 diabetes.
Lobesug Tablets are formulated with Lobeglitazone 0.5 mg, a next-generation insulin sensitizer that enhances the body’s response to insulin. By reducing insulin resistance in peripheral tissues such as muscles and adipose tissue, Lobesug supports better glucose utilization and long-term glycemic control.
Lobeglitazone 0.5 mg helps regulate blood sugar through multiple actions:
Improves Insulin Sensitivity
Enhances insulin responsiveness in body cells, allowing efficient glucose uptake.
Reduces Insulin Resistance
Targets insulin receptors to lower resistance, a major contributor to high blood glucose levels.
Controls Hepatic Glucose Output
Helps regulate excessive glucose production by the liver.
Supports Glycemic Stability
Assists in maintaining balanced fasting and postprandial glucose levels, contributing to improved HbA1c control.
Lobesug Tablets are indicated for:
Type 2 Diabetes Mellitus
Management of insulin resistance
Control of hyperglycemia
Adjunct therapy when diet and exercise alone are insufficient
Helps maintain optimal blood glucose levels
Improves insulin sensitivity
Supports long-term glycemic control
Low risk of hypoglycemia when used alone
Minimal impact on body weight
Convenient once-daily dosing
Recommended Dose: One tablet of Lobesug 0.5 mg once daily
Dose Adjustment: As advised by the healthcare professional
Maximum Dose: Up to 1 mg per day under medical supervision
Lobesug Tablets should preferably be taken with meals. Always follow the dosage prescribed by the physician.
Use with caution in patients with liver disorders; periodic monitoring is advised
Not recommended in patients with severe heart failure
Use during pregnancy and breastfeeding only under medical advice
Regular blood glucose monitoring is recommended
Inform your doctor about all medications being taken
Lobeglitazone 0.5 mg may interact with:
Insulin and insulin secretagogues
CYP2C8 inhibitors
Diuretics and antihypertensive medications
Always consult a healthcare professional before combining therapies.
Lobesug Tablets (Lobeglitazone 0.5 mg) are an effective treatment option for Type 2 Diabetes Mellitus, helping improve insulin sensitivity and regulate blood glucose levels. With a convenient once-daily dosing regimen, Lobesug supports consistent glycemic control and long-term diabetes management when used as prescribed.
PREGICOB M 50 Tablet, Pregicob M Tablet, Pregabalin Methylcobalamin Tablet, Pregabalin 50 mg Methylcobalamin 500 mcg, Neuropathic pain tablet, Diabetic neuropathy medicine, Nerve pain treatment tablet, Sciatica pain medicine, Post herpetic neuralgia tablet, Peripheral neuropathy medicine, Nerve repair tablet, Vitamin B12 neuropathy tablet, Neuro pain relief medicine, Pregabalin combination tablet, Neurology tablet medicine, Pregabalin Methylcobalamin tablet supplier in India, Pregabalin Methylcobalamin tablet manufacturer in India, PREGICOB M wholesaler India, Pregabalin tablet exporter India, PCD pharma neuropathy tablet India, Pregabalin PCD franchise India, Neurology PCD franchise India, Nerve pain medicine franchise India, PREGICOB M PCD franchise, Pregabalin monopoly franchise India, Best neuropathy tablet in India, Pregabalin Methylcobalamin tablet uses in India, PREGICOB M Tablet India